BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 20141066)

  • 1. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
    Bhaijee F; Locketz ML; Krige JE
    S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surgical therapy of hepatic fibrolamellar carcinoma].
    Meriggi F; Forni E
    Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of patients with fibrolamellar hepatocellular carcinoma.
    Stipa F; Yoon SS; Liau KH; Fong Y; Jarnagin WR; D'Angelica M; Abou-Alfa G; Blumgart LH; DeMatteo RP
    Cancer; 2006 Mar; 106(6):1331-8. PubMed ID: 16475212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiorgan resection in combination with intraoperative, hyperthermic chemotherapy in recurrent fibrolamellar hepatocellular carcinoma. An individual therapeutic concept for a 21-year-old patient].
    Braune C; Fangmann J; Scheumann GF; Klempnauer J
    Zentralbl Chir; 2001 Apr; 126(4):318-21; discussion 322. PubMed ID: 11370396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three decades' experience in surgery of hepatocellular carcinoma.
    Tang ZY; Yu YQ; Zhou XD; Yang BH; Lin ZY; Lu JZ; Ma ZC; Ye SL; Liu KD
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():126-33. PubMed ID: 9210895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle embolization of recurrent hepatocellular carcinoma after hepatectomy.
    Covey AM; Maluccio MA; Schubert J; BenPorat L; Brody LA; Sofocleous CT; Getrajdman GI; Fong Y; Brown KT
    Cancer; 2006 May; 106(10):2181-9. PubMed ID: 16596622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
    Neeff H; Makowiec F; Harder J; Gumpp V; Klock A; Thimme R; Drognitz O; Hopt UT
    Zentralbl Chir; 2009 Apr; 134(2):127-35. PubMed ID: 19382043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
    Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
    Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrolamellar hepatocarcinoma. Case report].
    Luque Vásquez C; Chávez I; Caycho R; Hipólito M
    Rev Gastroenterol Peru; 2001; 21(2):140-7. PubMed ID: 12172567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrolamellar carcinoma of the liver.
    Yamaguchi R; Tajika T; Kanda H; Nakanishi K; Kawanishi J
    Hepatogastroenterology; 1999; 46(27):1706-9. PubMed ID: 10430327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions.
    Lee SG; Hwang S; Jung JP; Lee YJ; Kim KH; Ahn CS
    Br J Surg; 2007 Mar; 94(3):320-6. PubMed ID: 17205495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome.
    Chen WT; Chau GY; Lui WY; Tsay SH; King KL; Loong CC; Wu CW
    Eur J Surg Oncol; 2004 May; 30(4):414-20. PubMed ID: 15063895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables.
    Kornberg A; Küpper B; Tannapfel A; Katenkamp K; Thrum K; Habrecht O; Wilberg J
    Eur J Surg Oncol; 2010 Mar; 36(3):275-80. PubMed ID: 19857941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of stage IVA hepatocellular carcinoma: should we reappraise the role of surgery?
    Chirica M; Scatton O; Massault PP; Aloia T; Randone B; Dousset B; Legmann P; Soubrane O
    Arch Surg; 2008 Jun; 143(6):538-43; discussion 543. PubMed ID: 18559745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
    Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
    J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of early hepatocellular carcinoma after hepatic resection.
    Maeda T; Shimada M; Harimoto N; Tsujita E; Aishima S; Tanaka S; Shirabe K; Maehara Y
    Hepatogastroenterology; 2008; 55(85):1428-32. PubMed ID: 18795705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of hepatic resection and transplantation for fibrolamellar carcinoma.
    Ringe B; Wittekind C; Weimann A; Tusch G; Pichlmayr R
    Surg Gynecol Obstet; 1992 Oct; 175(4):299-305. PubMed ID: 1329242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.